Trial · NCT02842242
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Post-exercise Peak LVOT Gradient From Baseline to Week 12 | Cohort A | -89.5 | 95% Confidence Interval -138.3 to -40.7 | mm Hg | |
| Change in Post-exercise Peak LVOT Gradient From Baseline to Week 12 | Cohort B | -25.0 | 95% Confidence Interval -47.1 to -3.0 | mm Hg | |
| Number of Participants Achieving a Post-exercise Peak LVOT Gradient Response of < 30 mmHg. Gradient < 30 mmHg | Cohort A | 8 | Participants | ||
| Number of Participants Achieving a Post-exercise Peak LVOT Gradient Response of < 30 mmHg. Gradient < 30 mmHg | Cohort B | 0 | Participants | ||
| Change in Dyspnea Symptom Score From Baseline to Week 12 | Cohort A | -3.1 | 95% Confidence Interval -4.1 to -2.1 | units on a scale | |
| Change in Dyspnea Symptom Score From Baseline to Week 12 | Cohort B | -3.0 | 95% Confidence Interval -5.0 to -1.0 | units on a scale | |
| Change in Peak VO2 From Baseline to Week 12 | Cohort A | 3.5 | 95% Confidence Interval 1.2 to 5.9 | mL/kg/min | |
| Change in Peak VO2 From Baseline to Week 12 | Cohort B | 1.7 | 95% Confidence Interval 0.03 to 3.3 | mL/kg/min | |
| Change in VE/VCO2 From Baseline to Week 12 | Cohort A | -2.2 | 95% Confidence Interval -6.1 to 1.7 | Ratio | |
| Change in VE/VCO2 From Baseline to Week 12 | Cohort B | -2.5 | 95% Confidence Interval -4.3 to -0.7 | Ratio | |
| Change in Resting LVEF From Baseline to Week 12 | Cohort A | -14.6 | 95% Confidence Interval -23.1 to -6.2 | Percent change | |
| Change in Resting LVEF From Baseline to Week 12 | Cohort B | -5.5 | 95% Confidence Interval -9.8 to -1.2 | Percent change | |
| Change in LV Fractional Shortening (LVFS) From Baseline to Week 12 | Cohort A | -18.60 | Standard Deviation 13.05 | Percent | |
| Change in LV Fractional Shortening (LVFS) From Baseline to Week 12 | Cohort B | -3.98 | Standard Deviation 11.42 | Percent | |
| Change in Global Longitudinal Strain (GLS) From Baseline to Week 12 | Cohort A | 0.56 | Standard Deviation 3.778 | Percent | |
| Change in Global Longitudinal Strain (GLS) From Baseline to Week 12 | Cohort B | 0.18 | Standard Deviation 2.806 | Percent | |
| Change in Post-exercise Peak LVOT Gradient From Week 12 to Week 16 | Cohort A | 55.22 | Standard Deviation 40.84 | mm Hg | |
| Change in Post-exercise Peak LVOT Gradient From Week 12 to Week 16 | Cohort B | 84.08 | Standard Deviation 28.38 | mm Hg |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02842242/results